For research use only
| Cat No. | ABC-TC1175 |
| Product Type | Human Pancreas Cancer Cell Lines |
| Cell Type | Epithelial-like |
| Species | Human |
| Growth Conditions | 37 ℃, 5% CO2 |
| Product Code | Suit-2; SUIT 2; SUIT2; Suit2; SUIzo Tumor-2 |
SUIT-2 human pancreatic cancer line from Japanese male liver metastasis shows epithelial morphology, pancreatic markers,aneuploidy,tumorigenic metastatic.
| Product Code | Suit-2; SUIT 2; SUIT2; Suit2; SUIzo Tumor-2 |
| Species | Human |
| Cat.No | ABC-TC1175 |
| Product Category | Tumor Cell Lines |
| Size/Quantity | 1 vial |
| Cell Type | Epithelial-like |
| Shipping Info | Dry Ice |
| Growth Conditions | 37 ℃, 5% CO2 |
| Biosafety Level | 1 |
| Storage | Liquid Nitrogen |
| Product Type | Human Pancreas Cancer Cell Lines |
SUIT-2 is a useful tool to investigate the biological activity of pancreatic ductal adenocarcinoma, identify novel targets or markers for diagnosis, prognosis, and therapy, and contribute to understanding of the interactions between cancer and the host. For example, SUIT-2 can be used to demonstrate how growth factors regulate cell proliferation of tumor cells and the impact of motility-related factors on migration and metastasis.
When you publish your research, please cite our product as “AcceGen Biotech Cat.# XXX-0000”. In return, we’ll give you a $100 coupon. Simply click here and submit your paper’s PubMed ID (PMID).
Chen WC, To MD, Westcott PMK, et al. Targeting KRAS4A splicing through the RBM39/DCAF15 pathway inhibits cancer stem cells. Nat Commun. 2021;12(1):4288. Published 2021 Jul 13. doi:10.1038/s41467-021-24498-7
